Merus N.V. (MRUS) NASDAQ
$41.30 0.48 (1.18%)
Market Cap: $2.40B
As of 04/24/24 03:03 PM EDT. Market open.
Merus N.V. (MRUS)
NASDAQ
$41.30
0.48 (1.18%)
Market Cap: $2.40B
As of 04/24/24 03:03 PM EDT. Market open.
Add to Portfolio
merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. our most advanced development programs use the biclonics® format. biclonics® are capable of simultaneously attacking tumors in multiple ways. for example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Sven Lundberg
Full Time Employees
202
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Sven Lundberg
Full Time Employees
202
URL
Address
Yalelaan 62, Utrecht, Utrecht, 3584 CM.
PRICE CHART FOR MERUS N.V
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$41.20
Previous Close
$40.82
Days Range
$40.71 - $41.77
52 week range
$18.21 - $52.04
Volume
423,631
Avg. Volume (30 days)
493,170
Market Cap
$2.40B
Dividend Yield
-
P/E
-
Shares Outstanding
58,687,551
Open
$41.20
Previous Close
$40.82
Days Range
$40.71 - $41.77
52 week range
$18.21 - $52.04
Volume
423,631
Avg. Volume (30 days)
493,170
Market Cap
$2.40B
Dividend Yield
-
P/E
-
Shares Outstanding
58,687,551
FINANCIAL STATEMENTS FOR MERUS N.V
LOADING...
INSIDER TRANSACTIONS FOR MERUS N.V
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Shuman Harry | VP Controller, PAO | Dec 19, 2023 | Sale | $26.68 | 115 | 3,068 | 7,002 | Dec 20, 2023, 04:05 PM |
Silverman Peter B. | COO & GC | Dec 15, 2023 | Sale | $25.00 | 22,386 | 559,650 | 0 | Dec 18, 2023, 05:15 PM |
Shuman Harry | VP Controller, PAO | Dec 08, 2023 | Sale | $24.44 | 250 | 6,110 | 7,117 | Dec 12, 2023, 04:04 PM |
Shuman Harry | VP Controller, PAO | Dec 01, 2023 | Sale | $24.58 | 575 | 14,133 | 7,367 | Dec 04, 2023, 04:05 PM |
Shuman Harry | VP Controller, PAO | Jun 01, 2023 | Sale | $21.48 | 575 | 12,351 | 5,442 | Jun 01, 2023, 04:21 PM |
Iwicki Mark T | Director | Apr 14, 2023 | Option Exercise | $7.27 | 73,576 | 534,679 | 73,576 | Apr 17, 2023, 08:26 AM |
Liu Hui | EVP, CBO & Head of Merus US | Apr 06, 2023 | Option Exercise | $7.86 | 98,085 | 770,948 | 156,016 | Apr 10, 2023, 12:43 PM |
Shuman Harry | VP Controller, PAO | Dec 13, 2022 | Sale | $13.85 | 168 | 2,327 | 3,517 | Dec 14, 2022, 04:45 PM |
Shuman Harry | VP Controller, PAO | Dec 01, 2022 | Sale | $15.35 | 575 | 8,826 | 3,685 | Dec 01, 2022, 04:34 PM |
Lundberg Sven Ante | President, CEO & PFO | Nov 03, 2022 | Buy | $14.38 | 14,706 | 211,431 | 40,576 | Nov 03, 2022, 02:07 PM |
Shuman Harry | VP Controller, PAO | Aug 25, 2022 | Sale | $24.33 | 165 | 4,014 | 1,760 | Aug 29, 2022, 10:13 AM |
Lundberg Sven Ante | President, CEO & PFO | Aug 22, 2022 | Buy | $22.92 | 5,826 | 133,558 | 25,870 | Aug 23, 2022, 04:09 PM |
Lundberg Sven Ante | President, CEO & PFO | Aug 19, 2022 | Buy | $22.99 | 704 | 16,187 | 20,044 | Aug 22, 2022, 03:02 PM |
Lundberg Sven Ante | President, CEO & PFO | Jul 12, 2022 | Buy | $22.97 | 4,340 | 99,685 | 19,340 | Jul 13, 2022, 10:13 AM |
Shuman Harry | VP Controller, PAO | Jun 01, 2022 | Sale | $18.31 | 575 | 10,528 | 1,925 | Jun 03, 2022, 04:00 PM |
Silverman Peter B. | EVP, GC and Head of Utrecht | Mar 10, 2022 | Option Exercise | $11.16 | 60,000 | 669,600 | 60,000 | Mar 11, 2022, 02:34 PM |
Silverman Peter B. | EVP, GC and Head of Utrecht | Mar 10, 2022 | Sale | $26.95 | 60,000 | 1,617,000 | 0 | Mar 11, 2022, 02:34 PM |
BVF PARTNERS L P/IL | 10% Owner | Oct 08, 2021 | Sale | $27.79 | 147,267 | 4,092,035 | 2,085,664 | Oct 08, 2021, 09:24 PM |
BVF PARTNERS L P/IL | 10% Owner | Oct 07, 2021 | Sale | $27.53 | 985,447 | 27,130,439 | 2,165,675 | Oct 08, 2021, 09:24 PM |
de Kruif John | SVP & Chief Technology Officer | Aug 12, 2021 | Sale | $19.34 | 2,787 | 53,901 | 15,282 | Aug 16, 2021, 09:24 AM |
Lundberg Sven Ante | President, CEO & PFO | Aug 02, 2021 | Option Exercise | $13.36 | 15,000 | 200,474 | 15,000 | Aug 04, 2021, 03:56 PM |
BVF PARTNERS L P/IL | 10% Owner | Jul 02, 2021 | Sale | $20.75 | 2,186,022 | 45,359,957 | 2,696,674 | Jul 07, 2021, 04:49 PM |
Bakker Lex | SVP, Chief Development Officer | Jul 02, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 15,668 | Jul 07, 2021, 11:35 AM |
Bakker Lex | SVP, Chief Development Officer | Jul 01, 2021 | Sale | $21.05 | 3,860 | 81,242 | 10,428 | Jul 06, 2021, 12:00 PM |
BVF PARTNERS L P/IL | 10% Owner | Mar 30, 2021 | Buy | $19.75 | 300,000 | 5,925,000 | 3,803,152 | Apr 01, 2021, 05:18 PM |
BVF PARTNERS L P/IL | 10% Owner | Mar 22, 2021 | Buy | $22.75 | 79,500 | 1,808,625 | 3,638,152 | Mar 24, 2021, 05:15 PM |
BVF PARTNERS L P/IL | 10% Owner | Mar 16, 2021 | Buy | $23.00 | 250,000 | 5,749,900 | 3,566,396 | Mar 18, 2021, 06:07 PM |
Lundberg Sven Ante | President, CEO & PFO | Mar 01, 2021 | Option Exercise | $13.38 | 74,000 | 989,867 | 74,000 | Mar 03, 2021, 12:00 AM |
BVF PARTNERS L P/IL | 10% Owner | Jan 21, 2021 | Buy | $24.75 | 844,680 | 20,905,830 | 3,513,335 | Jan 25, 2021, 06:51 PM |
INCYTE CORP | 10% Owner | Jan 25, 2021 | Option Exercise | $24.75 | 350,000 | 8,662,500 | 3,550,000 | Jan 25, 2021, 04:48 PM |
BVF PARTNERS L P/IL | 10% Owner | Dec 18, 2020 | Buy | $16.05 | 160,000 | 2,568,000 | 3,055,521 | Dec 22, 2020, 07:04 PM |
BVF PARTNERS L P/IL | 10% Owner | Sep 15, 2020 | Buy | $11.75 | 146,754 | 1,724,360 | 2,940,553 | Sep 17, 2020, 07:42 PM |
BVF PARTNERS L P/IL | 10% Owner | Sep 10, 2020 | Buy | $11.10 | 189,651 | 2,104,785 | 2,862,802 | Sep 14, 2020, 08:14 PM |
BVF PARTNERS L P/IL | 10% Owner | Sep 03, 2020 | Buy | $11.17 | 201,906 | 2,255,290 | 2,762,341 | Sep 08, 2020, 07:08 PM |
Throsby Mark | EVP & Chief Scientific Officer | Jul 07, 2020 | Sale | $15.46 | 368 | 5,689 | 45,515 | Jul 09, 2020, 04:00 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 08, 2020 | Buy | $15.20 | 87,254 | 1,326,261 | 2,657,514 | Jun 10, 2020, 07:03 PM |
Throsby Mark | EVP & Chief Scientific Officer | Jun 02, 2020 | Sale | $14.19 | 368 | 5,222 | 45,175 | Jun 04, 2020, 04:00 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 01, 2020 | Buy | $14.00 | 1,462,510 | 20,475,140 | 2,610,548 | Jun 03, 2020, 06:17 PM |
Throsby Mark | EVP & Chief Scientific Officer | May 06, 2020 | Sale | $14.54 | 368 | 5,351 | 44,835 | May 11, 2020, 08:00 AM |
Throsby Mark | EVP & Chief Scientific Officer | Apr 02, 2020 | Sale | $10.93 | 368 | 4,022 | 44,495 | Apr 06, 2020, 04:00 PM |
Throsby Mark | EVP & Chief Scientific Officer | Mar 04, 2020 | Sale | $18.10 | 368 | 6,661 | 44,155 | Mar 10, 2020, 05:00 PM |
Throsby Mark | EVP & Chief Scientific Officer | Feb 24, 2020 | Sale | $17.74 | 57,088 | 1,012,741 | 43,815 | Feb 26, 2020, 09:17 PM |
de Kruif John | SVP & Chief Technology Officer | Feb 18, 2020 | Sale | $18.98 | 1,268 | 24,067 | 11,649 | Feb 20, 2020, 05:00 PM |
BVF PARTNERS L P/IL | 10% Owner | Jan 16, 2020 | Buy | $16.15 | 278,730 | 4,501,489 | 1,804,105 | Jan 21, 2020, 05:21 PM |
BVF PARTNERS L P/IL | 10% Owner | Jan 13, 2020 | Buy | $14.98 | 83,962 | 1,257,616 | 1,657,663 | Jan 15, 2020, 06:32 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Shuman Harry | VP Controller, PAO | 12/19/2023 | 3,068 |
Silverman Peter B. | COO & GC | 12/15/2023 | 559,650 |
Shuman Harry | VP Controller, PAO | 12/08/2023 | 6,110 |
Shuman Harry | VP Controller, PAO | 12/01/2023 | 14,133 |
Shuman Harry | VP Controller, PAO | 06/01/2023 | 12,351 |
Iwicki Mark T | Director | 04/14/2023 | 534,679 |
Liu Hui | EVP, CBO & Head of Merus US | 04/06/2023 | 770,948 |
Shuman Harry | VP Controller, PAO | 12/13/2022 | 2,327 |
Shuman Harry | VP Controller, PAO | 12/01/2022 | 8,826 |
Lundberg Sven Ante | President, CEO & PFO | 11/03/2022 | 211,431 |
Shuman Harry | VP Controller, PAO | 08/25/2022 | 4,014 |
Lundberg Sven Ante | President, CEO & PFO | 08/22/2022 | 133,558 |
Lundberg Sven Ante | President, CEO & PFO | 08/19/2022 | 16,187 |
Lundberg Sven Ante | President, CEO & PFO | 07/12/2022 | 99,685 |
Shuman Harry | VP Controller, PAO | 06/01/2022 | 10,528 |
Silverman Peter B. | EVP, GC and Head of Utrecht | 03/10/2022 | 669,600 |
Silverman Peter B. | EVP, GC and Head of Utrecht | 03/10/2022 | 1,617,000 |
BVF PARTNERS L P/IL | 10% Owner | 10/08/2021 | 4,092,035 |
BVF PARTNERS L P/IL | 10% Owner | 10/07/2021 | 27,130,439 |
de Kruif John | SVP & Chief Technology Officer | 08/12/2021 | 53,901 |
Lundberg Sven Ante | President, CEO & PFO | 08/02/2021 | 200,474 |
BVF PARTNERS L P/IL | 10% Owner | 07/02/2021 | 45,359,957 |
Bakker Lex | SVP, Chief Development Officer | 07/02/2021 | 13,510 |
Bakker Lex | SVP, Chief Development Officer | 07/01/2021 | 81,242 |
BVF PARTNERS L P/IL | 10% Owner | 03/30/2021 | 5,925,000 |
BVF PARTNERS L P/IL | 10% Owner | 03/22/2021 | 1,808,625 |
BVF PARTNERS L P/IL | 10% Owner | 03/16/2021 | 5,749,900 |
Lundberg Sven Ante | President, CEO & PFO | 03/01/2021 | 989,867 |
BVF PARTNERS L P/IL | 10% Owner | 01/21/2021 | 20,905,830 |
INCYTE CORP | 10% Owner | 01/25/2021 | 8,662,500 |
BVF PARTNERS L P/IL | 10% Owner | 12/18/2020 | 2,568,000 |
BVF PARTNERS L P/IL | 10% Owner | 09/15/2020 | 1,724,360 |
BVF PARTNERS L P/IL | 10% Owner | 09/10/2020 | 2,104,785 |
BVF PARTNERS L P/IL | 10% Owner | 09/03/2020 | 2,255,290 |
Throsby Mark | EVP & Chief Scientific Officer | 07/07/2020 | 5,689 |
BVF PARTNERS L P/IL | 10% Owner | 06/08/2020 | 1,326,261 |
Throsby Mark | EVP & Chief Scientific Officer | 06/02/2020 | 5,222 |
BVF PARTNERS L P/IL | 10% Owner | 06/01/2020 | 20,475,140 |
Throsby Mark | EVP & Chief Scientific Officer | 05/06/2020 | 5,351 |
Throsby Mark | EVP & Chief Scientific Officer | 04/02/2020 | 4,022 |
Throsby Mark | EVP & Chief Scientific Officer | 03/04/2020 | 6,661 |
Throsby Mark | EVP & Chief Scientific Officer | 02/24/2020 | 1,012,741 |
de Kruif John | SVP & Chief Technology Officer | 02/18/2020 | 24,067 |
BVF PARTNERS L P/IL | 10% Owner | 01/16/2020 | 4,501,489 |
BVF PARTNERS L P/IL | 10% Owner | 01/13/2020 | 1,257,616 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MERUS N.V
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,019,901 | 1.53% | -22.11% | Other |
BLACKROCK INC. | 1,429,893 | 0.001% | -2.46% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,311,013 | 0.43% | 15.49% | Growth |
BALYASNY ASSET MANAGEMENT L.P. | 1,233,238 | 0.06% | 43.34% | Event Driven |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 330,000 | 0.02% | 230% | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 142,029 | 0.16% | No change | Growth At A Reasonable Price, Value |
UBS OCONNOR LLC | 121,300 | 0.24% | -20.25% | Value |
D. E. SHAW & CO., INC. | 59,033 | 0.00142% | New | Other |
GEODE CAPITAL MANAGEMENT, LLC | 53,608 | 0.00015% | 0.28% | Other |
ALPS ADVISORS INC | 40,128 | 0.00868% | New | Other |
TUDOR INVESTMENT CORP ET AL | 24,443 | 0.00541% | 3.41% | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR MERUS N.V
STOCK BUYBACKS FOR MERUS N.V
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
7.34%
1Q
06/30/2023
19.66%
2Q
03/31/2023
24.82%
3Q
12/31/2022
24.83%
4Q
09/30/2022
25.55%
5Q
06/30/2022
32.51%
6Q
03/31/2022
32.96%
7Q
12/31/2021
39.57%
8Q
09/30/2021
50.14%
9Q
06/30/2021
50.68%
10Q
03/31/2021
59.69%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MERUS N.V
LOADING...